NCT07256535

Brief Summary

Analgesia methods such as systemic analgesics, quadratus lumborum block, and transversus abdominis plane block are used for pain management after lower abdominal surgery. Quadratus lumborum block (QLB) requires the patient to be in the lateral decubitus position, and the drug injection point is deeper. Transversus abdominis plane (TAP) block, on the other hand, can be performed with the patient supine, and the drug injection point is more superficial. However, while TAP block has no effect on visceral pain, QLB is also effective in visceral pain. Furthermore, although the injection point for QLB is deep, systemic absorption of the drug is expected to be lower than with TAP block due to its distance from vascular structures. Consequently, blood local anesthetic concentrations and the risk of local anesthetic systemic toxicity (LAST) are also expected to be lower. Despite the deeper injection, it is expected to provide better analgesia and a lower risk of LAST, making it superior to TAP block. This study aimed to compare the postoperative pain relief effect of quadratus lumborum block and transversus abdominis plane block, routinely performed in the clinic to prevent postoperative pain in pediatric patients undergoing inguinal hernia surgery, using the FLACC (Face, Leg Mobility, Activity, Crying, and Consolability) score for blood bupivacaine dose after drug injection. Based on these data, if lower blood drug concentrations are detected in patients undergoing QLB, the investigators aim to implement this technique routinely in clinical practice.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Jan 2026Jun 2026

First Submitted

Initial submission to the registry

November 20, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 1, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

January 25, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2026

Expected
Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

3 months

First QC Date

November 20, 2025

Last Update Submit

December 9, 2025

Conditions

Keywords

Pediatric PopulationTransversus Abdominis Plan BlockQuadratus Lumborum BlockBupivacaine

Outcome Measures

Primary Outcomes (2)

  • Blood bupivacaine level

    After the block application, 2 mL of blood will be taken into a routine biochemistry tube and the blood bupivacaine level will be measured.

    30 and 60 minutes after block application

  • FLACC (Face, Leg Mobility, Activity, Crying, Consolation)

    To compare postoperative pain efficacy with FLACC (Face, Leg Mobility, Activity, Crying, Consolability) Minimum score is 0 (no pain), maximum score 10 (the worse pain).

    0.HOUR, 1.HOUR, 2.HOUR, 4.HOUR, 6.HOUR, 12.HOUR 24.HOUR

Study Arms (2)

GROUP USING Transversus Abdominis Plane Block

ACTIVE COMPARATOR

After induction of general anesthesia in all patients, once airway security is ensured, the standard regional anesthesia technique will be performed under ultrasound guidance by the same physician. A transversus abdominis plane block will be performed using an in-plane approach, passing through the external oblique and internal oblique muscles visible on ultrasound, and then advancing toward the fascial layer separating the internal oblique and transversus abdominis muscles. Following the block, the surgical team will begin the procedure. Thirty and sixty minutes after the block, 2 mL of blood will be collected into a routine biochemistry tube, and the blood bupivacaine level will be measured.

Procedure: Transversus Abdominis Plane Block

GROUP USING Quadratus Lumborum Block

ACTIVE COMPARATOR

After induction of general anesthesia in all patients, once airway security is ensured, the standard regional anesthesia technique will be performed by the same person under ultrasound guidance. The ultrasound probe is placed transversely, just above the iliac crest in the midaxillary line. After visualizing the vertebral body, transverse process, psoas major, quadratus lumborum, and erector spinae muscles, a local anesthetic will be administered between the quadratus lumborum and psoas major muscles, using an in-plane approach, as visible on ultrasound. Thirty and 60 minutes after the block, 2 mL of blood will be collected in a routine biochemistry tube, and the blood bupivacaine level will be measured.

Procedure: Quadratus Lumborum Block

Interventions

transversus abdominis plane block will be performed using 0.25-0.5% cc/kg bupivacaine

GROUP USING Transversus Abdominis Plane Block

Quadratus Lumborum Block will be performed using 0.25-0.5% cc/kg bupivacaine

GROUP USING Quadratus Lumborum Block

Eligibility Criteria

Age1 Year - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients undergoing elective inguinal hernia surgery.
  • years of age
  • ASA I-II patients

You may not qualify if:

  • Vulnerable populations such as those incapacitated, those in intensive care, those unconscious, those unable to give personal consent, or impressionable individuals will not be included in the study.
  • Although pediatric patients who may be considered a vulnerable population will be included in the study, patients with serious illnesses such as ASA III-IV will not be included in this group.
  • Patients who refuse to participate in the observational study, their parents/legal guardians,
  • Patients with incomplete data
  • Patients who underwent surgery with an incision other than the planned one for any reason.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kocaeli University

Kocaeli, Turkey (Türkiye)

Location

Central Study Contacts

Can AKSU, Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 20, 2025

First Posted

December 1, 2025

Study Start

January 25, 2026

Primary Completion

April 25, 2026

Study Completion (Estimated)

June 25, 2026

Last Updated

December 17, 2025

Record last verified: 2025-12

Locations